SCHEMBL18848872

SCHEMBL18848872

CNC[C@H](O)CCC(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.48
SLC1A1 P43005 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
KISS1R Q969F8 2/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CA12 O43570 2/20 0.37
CA14 Q9ULX7 2/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
PABPC1 P11940 1/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
MGAM O43451 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12460192 1.00 TSHR (0.48) TSHRSLC1A1L3MBTL1KISS1RKMT2A
SCHEMBL13993150 0.82 TSHR (0.46) TSHRSLC1A1L3MBTL1KMT2AMEN1
SCHEMBL5313852 0.80
SCHEMBL28412888 0.78 TSHR (0.52) TSHRSLC1A1L3MBTL1KMT2AMEN1
SCHEMBL22675503 0.78 KISS1R (0.41) TSHRL3MBTL1KISS1RCA12CA14
SCHEMBL9962291 0.78 KISS1R (0.41) TSHRL3MBTL1KISS1RCA12CA14
SCHEMBL28032879 0.78 TSHR (0.52) TSHRSLC1A1L3MBTL1KMT2AMEN1
SCHEMBL20377437 0.78 TSHR (0.52) TSHRSLC1A1L3MBTL1KMT2AMEN1
SCHEMBL5750324 0.78 TSHR (0.52) TSHRSLC1A1L3MBTL1KMT2AMEN1
SCHEMBL7711607 0.78 TSHR (0.52) TSHRSLC1A1L3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9776987-B2 Amide derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2017-10-03 US disclosed
US-20170129875-A1 AMIDE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2017-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170129875-A1 AMIDE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GLP1R TSHR 332/4885SLC1A1 600/4885L3MBTL1 4723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.